speb/financial-data huggingface dataset:
Financial ratios for BAYA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -217212
Net income: -37574
Capital expenditures: 0
Operating cash flow: 5787
Net tangible assets: 6246336
Owner earnings: -37574
Return on net tangible assets (%): -0.6015366448426726
Buffett classification: The Gruesome
Stock price: 11.88
P/E ratio: 160.56796410643685
Shares outstanding: 2738292
Book value: 6246336
P/B ratio: 5.2079985706820775
Market cap (USD): 32530908.96
Debt to equity: 0.284166589821617
Current ratio: 0.015132160159486882
Quick ratio: 0.015132160159486882
Free cash flow (dilution-adjusted): 5787
Buyback yield (%): 25.995756867409707
Retained earnings: -5514827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6024832932678486
Rule of 40 score: 0
Financial ratios for BAYA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -986503
Net income: 202599
Capital expenditures: 0
Operating cash flow: -49491
Net tangible assets: 6246336
Owner earnings: 202599
Return on net tangible assets (%): 3.2434854609166077
Buffett classification: The Gruesome
Stock price: 11.88
P/E ratio: 160.56796410643685
Shares outstanding: 2738292
Book value: 6246336
P/B ratio: 5.2079985706820775
Market cap (USD): 32530908.96
Debt to equity: 0.284166589821617
Current ratio: 0.015132160159486882
Quick ratio: 0.015132160159486882
Free cash flow (dilution-adjusted): -49491
Buyback yield (%): 93.09041145218588
Retained earnings: -5514827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.819593651633484
Rule of 40 score: 0
Financial ratios for BBB.V — annual report dated 2021-09-30
Capital expenditures: 0
Depreciation & amortization: 95832.03125
Buffett classification: The Gruesome
Stock price: 1.015625
Shares outstanding: 74204658
Market cap (USD): 75364105.78125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBB.V — annual report dated 2022-09-30
Total revenue: 0
Gross profit: -115070.80291970802
Operating income: -10239945.255474452
Net income: -9177906.569343066
Capital expenditures: 70336.49635036496
Operating cash flow: -9366886.131386861
Depreciation & amortization: 115070.80291970802
Net tangible assets: 11088797.810218977
Owner earnings: -9133172.262773722
Return on net tangible assets (%): -82.36395341573429
Buffett classification: The Gruesome
Stock price: 1.4233576642335766
Shares outstanding: 74204658
Book value: 11088797.810218977
P/B ratio: 9.52490707232452
Market cap (USD): 105619768.68613139
Debt to equity: 0.00870194968249999
Current ratio: 3.5136534625375035
Quick ratio: 3.5136534625375035
Interest coverage ratio: -1177.4003357112883
Free cash flow (dilution-adjusted): -9813053.284671532
Buyback yield (%): 0
Retained earnings: -47271160.5839416
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -89.79565567155589
Rule of 40 score: 0
Financial ratios for BBB.V — annual report dated 2023-09-30
Total revenue: 0
Gross profit: -92451.11111111111
Operating income: -13374334.074074073
Net income: -12550946.666666666
Capital expenditures: 9821.48148148148
Operating cash flow: -13061337.777777776
Depreciation & amortization: 92451.11111111111
Net tangible assets: 10108865.185185185
Owner earnings: -12468317.037037035
Return on net tangible assets (%): -123.34042257591575
Buffett classification: The Gruesome
Stock price: 1.1851851851851851
Shares outstanding: 74204658
Book value: 10108865.185185185
P/B ratio: 8.699914354602429
Market cap (USD): 87946261.33333333
Debt to equity: 0.006807739272195846
Current ratio: 2.9217337588482892
Quick ratio: 2.9217337588482892
Interest coverage ratio: -1069.5664356376992
Free cash flow (dilution-adjusted): -13500593.333333334
Buyback yield (%): 0
Retained earnings: -60522420.74074074
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -128.47185503561812
Rule of 40 score: 0
Financial ratios for BBB.V — annual report dated 2024-09-30
Total revenue: 0
Gross profit: -74479.25925925926
Operating income: -12061858.518518517
Net income: -10036453.333333332
Capital expenditures: 62351.85185185185
Operating cash flow: -9874166.666666666
Depreciation & amortization: 74479.25925925926
Net tangible assets: 9876309.629629629
Owner earnings: -10024325.925925925
Return on net tangible assets (%): -101.4987004442655
Buffett classification: The Gruesome
Stock price: 0.6296296296296295
Shares outstanding: 74204658
Book value: 9876309.629629629
P/B ratio: 4.730658827581272
Market cap (USD): 46721451.33333333
Debt to equity: 0.003706512659024386
Current ratio: 3.219962561921596
Quick ratio: 3.219962561921596
Interest coverage ratio: -1283.7834279407127
Free cash flow (dilution-adjusted): -10675962.222222222
Buyback yield (%): 0
Retained earnings: -70558874.07407407
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -119.63316239567415
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2024-09-30
Capital expenditures: 56319.259259259255
Depreciation & amortization: 18620
Buffett classification: The Gruesome
Stock price: 0.6296296296296295
Shares outstanding: 74204658
Market cap (USD): 46721451.33333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -14608.391608391608
Operating income: -1538862.937062937
Net income: -1014930.7692307692
Capital expenditures: 0
Operating cash flow: -2261460.13986014
Depreciation & amortization: 14608.391608391608
Net tangible assets: 11072840.55944056
Owner earnings: -1000322.3776223776
Return on net tangible assets (%): -9.034017714357095
Buffett classification: The Gruesome
Stock price: 0.4195804195804196
Shares outstanding: 74204658
Book value: 11072840.559440559
P/B ratio: 2.8118188256505143
Market cap (USD): 31134821.53846154
Debt to equity: 0.002376633509244127
Current ratio: 4.616232546678166
Quick ratio: 4.616232546678166
Interest coverage ratio: -653.7653000594178
Free cash flow (dilution-adjusted): -2261460.13986014
Buyback yield (%): 0
Retained earnings: -67626455.24475525
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.657690029458161
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -14608.391608391608
Operating income: -724934.2657342658
Net income: -99672.72727272728
Capital expenditures: 3406.993006993007
Operating cash flow: -211776.9230769231
Depreciation & amortization: 14608.391608391608
Net tangible assets: 10980553.146853147
Owner earnings: -88471.32867132868
Return on net tangible assets (%): -0.8057092159941248
Buffett classification: The Gruesome
Stock price: 0.4545454545454546
Shares outstanding: 74204658
Book value: 10980553.146853147
P/B ratio: 3.071738695574395
Market cap (USD): 33729390
Debt to equity: 0.0016269704017738674
Current ratio: 5.40281245283777
Quick ratio: 5.40281245283777
Interest coverage ratio: -262.31174089068827
Free cash flow (dilution-adjusted): -225711.18881118883
Buyback yield (%): 0
Retained earnings: -67729269.93006994
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.487057592460451
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -15438.68613138686
Operating income: -1818897.810218978
Net income: -1490381.02189781
Capital expenditures: 8159.85401459854
Operating cash flow: -1145315.3284671532
Depreciation & amortization: 15438.68613138686
Net tangible assets: 9990320.437956203
Owner earnings: -1483102.1897810218
Return on net tangible assets (%): -14.845391586703013
Buffett classification: The Gruesome
Stock price: 0.875912408759124
Shares outstanding: 74204658
Book value: 9990320.437956203
P/B ratio: 6.505975572413561
Market cap (USD): 64996780.729927
Debt to equity: 0.0009613685188268733
Current ratio: 3.565369334211021
Quick ratio: 3.565369334211021
Interest coverage ratio: -1597.3653846153845
Free cash flow (dilution-adjusted): -1169443.795620438
Buyback yield (%): 0
Retained earnings: -72182616.78832117
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.843924788403747
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -15700.719424460432
Operating income: -4354541.007194245
Net income: -3189828.057553957
Capital expenditures: 95.68345323741008
Operating cash flow: -4356055.395683453
Depreciation & amortization: 15700.719424460432
Net tangible assets: 7880151.798561152
Owner earnings: -3174223.0215827343
Return on net tangible assets (%): -40.281242071533704
Buffett classification: The Gruesome
Stock price: 0.5395683453237411
Shares outstanding: 74204658
Book value: 7880151.798561151
P/B ratio: 5.080928078020628
Market cap (USD): 40038484.53237411
Debt to equity: 0.013008641782911279
Current ratio: 3.4357942679973865
Quick ratio: 3.4357942679973865
Interest coverage ratio: -950.3551577955725
Free cash flow (dilution-adjusted): -4391393.525179856
Buyback yield (%): 0
Retained earnings: -74333846.04316548
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.39000923967815
Rule of 40 score: 0
Financial ratios for BBB.V — annual report dated 2025-09-30
Total revenue: 0
Gross profit: -60974.8201438849
Operating income: -8476210.071942447
Net income: -5805443.165467626
Capital expenditures: 11643.1654676259
Operating cash flow: -8029300.719424461
Depreciation & amortization: 60974.8201438849
Net tangible assets: 7880151.798561152
Owner earnings: -5756111.510791367
Return on net tangible assets (%): -73.04569325482262
Buffett classification: The Gruesome
Stock price: 0.5395683453237411
Shares outstanding: 74204658
Book value: 7880151.798561151
P/B ratio: 5.080928078020628
Market cap (USD): 40038484.53237411
Debt to equity: 0.013008641782911279
Current ratio: 3.4357942679973865
Quick ratio: 3.4357942679973865
Interest coverage ratio: -772.7377188955205
Free cash flow (dilution-adjusted): -8102755.395683453
Buyback yield (%): 0
Retained earnings: -74333846.04316548
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -103.92483003623103
Rule of 40 score: 0
Financial ratios for BBB.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -13742.335766423357
Operating income: -909170.802919708
Net income: -782513.8686131387
Capital expenditures: 0
Operating cash flow: -416788.3211678832
Depreciation & amortization: 13742.335766423357
Net tangible assets: 15362949.635036495
Owner earnings: -768771.5328467153
Return on net tangible assets (%): -5.004062052598723
Buffett classification: The Gruesome
Stock price: 0.40145985401459855
Shares outstanding: 74204658
Book value: 15362949.635036496
P/B ratio: 1.9390931999115704
Market cap (USD): 29790191.167883214
Debt to equity: 0.006321398609917565
Current ratio: 5.709016863809758
Quick ratio: 5.709016863809758
Interest coverage ratio: -267.8632258064516
Free cash flow (dilution-adjusted): -453405.10948905104
Buyback yield (%): 0
Retained earnings: -76182164.96350364
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.814963684138065
Rule of 40 score: 0
Financial ratios for BILI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.4
Shares outstanding: 338805755
Market cap (USD): 15720587032
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BILI — annual report dated 2022-12-31
Total revenue: 3146432040.229885
Gross profit: 553059626.4367816
Operating income: -1200854022.9885058
Net income: -1077157040.229885
Capital expenditures: 109256752.87356322
Operating cash flow: -561978448.2758621
Depreciation & amortization: 512366666.6666667
Net tangible assets: 1176136206.8965518
Owner earnings: -674047126.4367815
Return on net tangible assets (%): -57.31029471623672
Buffett classification: The Gruesome
Stock price: 23.69
Shares outstanding: 338805755
Book value: 2189595833.333333
P/B ratio: 3.6656574760334393
Market cap (USD): 8026308335.950001
Debt to equity: 1.0199241619868047
Current ratio: 1.4305452559361493
Quick ratio: 1.404953454560601
Interest coverage ratio: -33.30879991072958
COGS to revenue (%): 82.42264192058082
R&D to revenue (%): 21.760462395670118
SG&A to revenue (%): 33.98247522382929
Free cash flow (dilution-adjusted): -1104939224.137931
Buyback yield (%): 0.6222013503629473
Retained earnings: -3086188074.7126436
Inventory turnover: 41.26147157053019
Receivables turnover: 7.230781650813923
Capitalized R&D asset: 684678160.9195403
ROCI (R&D-adjusted, %): -17.561334691589913
FCF margin (%): -35.117212449222386
Rule of 40 score: -35.117212449222386
Financial ratios for BILI — annual report dated 2023-12-31
Total revenue: 3168493248.9451475
Gross profit: 765381856.5400844
Operating income: -712262587.90436
Net income: -676752883.2630098
Capital expenditures: 25583263.009845287
Operating cash flow: 37499578.05907173
Depreciation & amortization: 407832067.51054853
Net tangible assets: 1130694374.1209564
Owner earnings: -294504078.7623066
Return on net tangible assets (%): -26.046302652851256
Buffett classification: The Gruesome
Stock price: 12.17
Shares outstanding: 338805755
Book value: 2025916596.3431787
P/B ratio: 2.035259519465204
Market cap (USD): 4123266038.35
Debt to equity: 0.5307387734481733
Current ratio: 1.0344318659809502
Quick ratio: 1.0241302673294044
Interest coverage ratio: -30.705627338155672
COGS to revenue (%): 75.84398020116045
R&D to revenue (%): 19.830755406597138
SG&A to revenue (%): 26.804800624219112
Free cash flow (dilution-adjusted): -308884106.8917018
Buyback yield (%): 0
Retained earnings: -3700529676.511955
Inventory turnover: 91.61606889118859
Receivables turnover: 8.988931015660413
Capitalized R&D asset: 1087070514.0889473
ROCI (R&D-adjusted, %): -16.27672377260021
Rosenberg metric: 0.3101051592154605
FCF margin (%): -9.748611804507878
Revenue growth (%): 0.7011500147847011
Rule of 40 score: -9.047461789723176
Financial ratios for BILI — annual report dated 2024-12-31
Total revenue: 3675551369.8630137
Gross profit: 1201912739.7260275
Operating income: -184105342.46575344
Net income: -184493150.68493152
Capital expenditures: 63748904.10958904
Operating cash flow: 823952602.7397261
Depreciation & amortization: 342625342.46575344
Net tangible assets: 1120856849.3150685
Owner earnings: 94383287.67123288
Buffett classification: The Gruesome
Stock price: 18.11
Shares outstanding: 338805755
Book value: 1932042876.7123284
P/B ratio: 3.1757950597302327
Market cap (USD): 6135772223.05
Debt to equity: 0.358100124412282
Current ratio: 1.3382319739686293
Quick ratio: 1.3209462999675603
Interest coverage ratio: -15.068099514535895
COGS to revenue (%): 67.29979753293934
R&D to revenue (%): 13.734642365650107
SG&A to revenue (%): 23.97447778313011
Free cash flow (dilution-adjusted): 585718219.1780822
Buyback yield (%): 0.2623800315698131
Retained earnings: -3789240958.9041095
Inventory turnover: 70.76263103238827
Receivables turnover: 12.696145001324906
Capitalized R&D asset: 1151752846.7226996
ROCI (R&D-adjusted, %): -7.903891730701906
Rosenberg metric: 0.6947410009361127
FCF margin (%): 15.935519878202973
Revenue growth (%): 16.00313085996556
Rule of 40 score: 31.938650738168533
Financial ratios for BILI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.11
Shares outstanding: 338805755
Market cap (USD): 6135772223.05
Buyback yield (%): 0
Retained earnings: -3789240958.9041095
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BILI — quarterly report dated 2025-03-31
Total revenue: 964634710.7438017
Gross profit: 349738016.52892566
Operating income: 2067217.6308539945
Net income: -1253719.008264463
Capital expenditures: 4917217.630853995
Operating cash flow: 179351928.37465566
Depreciation & amortization: 73608402.20385675
Net tangible assets: 1165527823.6914601
Owner earnings: 67437465.56473829
Capex to operating income (%): 237.8664712153518
Buffett classification: The Gruesome
Stock price: 19.11
Shares outstanding: 338805755
Book value: 1980764187.3278236
P/B ratio: 3.268727302054373
Market cap (USD): 6474577978.05
Debt to equity: 0.36842182122435424
Current ratio: 1.3624426232840114
Quick ratio: 1.3469679823806733
Effective tax rate (%): 1272.008781558727
Interest coverage ratio: 0.4607779926928863
COGS to revenue (%): 63.74399421525555
R&D to revenue (%): 12.015524796494425
SG&A to revenue (%): 24.026180423711967
Free cash flow (dilution-adjusted): 85929201.10192838
Buyback yield (%): 0
Retained earnings: -3811372038.5674934
Inventory turnover: 19.09870326558028
Receivables turnover: 3.296848497687392
Capitalized R&D asset: 115905922.86501378
ROCI (R&D-adjusted, %): 3.028800083853959
FCF margin (%): 8.907952424360811
Rule of 40 score: 8.907952424360811
Financial ratios for BILI — quarterly report dated 2025-06-30
Total revenue: 1023387726.6387727
Gross profit: 373200278.9400279
Operating income: 35092329.14923292
Net income: 30544211.9944212
Capital expenditures: 20146164.57461646
Operating cash flow: 277442817.2942817
Depreciation & amortization: 74202092.05020921
Net tangible assets: 1174072245.4672246
Owner earnings: 84600139.47001395
Return on net tangible assets (%): 7.205701335384786
Capex to operating income (%): 57.40902659650573
Buffett classification: The Good
Stock price: 21.45
P/E ratio: 59.4824925101797
Shares outstanding: 338805755
Book value: 1974303765.6903768
P/B ratio: 3.6809854547426917
Market cap (USD): 7267383444.75
Debt to equity: 0.7094131589421068
Current ratio: 1.5967472358173478
Quick ratio: 1.583689296041205
Effective tax rate (%): 10.773790058862
Interest coverage ratio: 7.086464259561764
COGS to revenue (%): 63.532855707995296
R&D to revenue (%): 11.807721503633976
SG&A to revenue (%): 21.230387219956143
Free cash flow (dilution-adjusted): 183932914.92329147
Buyback yield (%): 0
Retained earnings: -3828669316.596932
Inventory turnover: 22.293313694922386
Receivables turnover: 3.2737186205185798
Capitalized R&D asset: 198495740.9834365
ROCI (R&D-adjusted, %): 2.2815910880178913
Rosenberg metric: 0.20242505155173846
FCF margin (%): 17.972945163941237
Revenue growth (%): 6.090700991846776
Rule of 40 score: 24.063646155788014
Financial ratios for BILI — quarterly report dated 2025-09-30
Total revenue: 1079418679.775281
Gross profit: 395776404.494382
Operating income: 49711797.75280899
Net income: 66043539.32584269
Capital expenditures: 0
Net tangible assets: 1297001123.5955057
Owner earnings: 66043539.32584269
Return on net tangible assets (%): 5.092018667089421
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 28.09
P/E ratio: 99.8285022373077
Shares outstanding: 338805755
Book value: 2091523735.9550562
P/B ratio: 4.550296749849799
Market cap (USD): 9517053657.95
Debt to equity: 0.6508619025334266
Current ratio: 1.6386925164032937
Quick ratio: 1.6386925164032937
Effective tax rate (%): -3.246517582004263
Interest coverage ratio: 8.400332265337605
COGS to revenue (%): 63.334300961256574
R&D to revenue (%): 11.769456640271807
SG&A to revenue (%): 20.29081924948939
Buyback yield (%): 0
Receivables turnover: 6.76586493555427
Capitalized R&D asset: 246252645.7133984
ROCI (R&D-adjusted, %): 1.5672859636497098
Rosenberg metric: 0.18682849102705995
Revenue growth (%): 5.475046424539111
Rule of 40 score: 5.475046424539111
Financial ratios for BILI — quarterly report dated 2025-12-31
Total revenue: 1188766714.2857144
Gross profit: 440177142.85714287
Operating income: 71983285.71428572
Net income: 73419142.85714285
Capital expenditures: 0
Net tangible assets: 1377936285.7142856
Owner earnings: 73419142.85714285
Return on net tangible assets (%): 5.328195767708107
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.59
P/E ratio: 49.36934375960367
Shares outstanding: 338805755
Book value: 2221223285.714286
P/B ratio: 3.7507411204591703
Market cap (USD): 8331233515.45
Debt to equity: 0.6293842717169426
Current ratio: 1.3553433234555083
Quick ratio: 1.3448902376797927
Effective tax rate (%): -1.1892245232272876
Interest coverage ratio: 12.484712586719525
COGS to revenue (%): 62.97194920017348
R&D to revenue (%): 11.06861408708449
SG&A to revenue (%): 19.904145556853816
Buyback yield (%): 0
Retained earnings: -3782055857.142857
Inventory turnover: 24.66174228162651
Receivables turnover: 3.7056121003984663
Capitalized R&D asset: 256574743.01278734
ROCI (R&D-adjusted, %): 2.383445601380391
Rosenberg metric: 0.3494973197811225
Revenue growth (%): 10.130270724349339
Rule of 40 score: 10.130270724349339
Financial ratios for BILI — annual report dated 2025-12-31
Total revenue: 4335395142.857142
Gross profit: 1587730285.7142856
Operating income: 160635857.14285713
Net income: 170504428.57142857
Capital expenditures: 73265428.57142857
Operating cash flow: 1021015428.5714285
Depreciation & amortization: 312499571.4285714
Net tangible assets: 1377936285.7142856
Owner earnings: 409738571.42857146
Return on net tangible assets (%): 29.735668889521538
Capex to operating income (%): 45.60963527979432
Buffett classification: The Good
Stock price: 24.59
P/E ratio: 48.86227053017475
Shares outstanding: 338805755
Book value: 2221223285.714286
P/B ratio: 3.7507411204591703
Market cap (USD): 8331233515.45
Debt to equity: 0.6293842717169426
Current ratio: 1.3553433234555083
Quick ratio: 1.3448902376797927
Effective tax rate (%): 1.4191870446309283
Interest coverage ratio: 7.467862550806259
COGS to revenue (%): 63.37749539784906
R&D to revenue (%): 11.643321620444814
SG&A to revenue (%): 21.273964614067474
Free cash flow (dilution-adjusted): 744286857.1428571
Buyback yield (%): 1.4107206136218873
Retained earnings: -3782055857.142857
Inventory turnover: 90.51983245481928
Receivables turnover: 13.514251794165688
Capitalized R&D asset: 1050366898.1330559
ROCI (R&D-adjusted, %): 2.965488740137559
Rosenberg metric: 0.7642617459160538
FCF margin (%): 17.167682128562607
Revenue growth (%): 17.95223917707674
Rule of 40 score: 35.11992130563935
Financial ratios for BLKB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 78.98
Shares outstanding: 45932106
Market cap (USD): 3627717731.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLKB — annual report dated 2022-12-31
Total revenue: 1058105000
Gross profit: 552716000
Operating income: -28485000
Net income: -45407000
Capital expenditures: 12289000
Operating cash flow: 203893000
Depreciation & amortization: 102369000
Net tangible assets: -1082399000
Owner earnings: 44673000
Buffett classification: The Gruesome
Stock price: 58.86
Shares outstanding: 45932106
Book value: 744032000
P/B ratio: 3.6336659702270873
Market cap (USD): 2703563759.16
Debt to equity: 1.2149490882112597
Current ratio: 0.7464746043122208
Quick ratio: 0.7464746043122208
Interest coverage ratio: -0.7956037203586291
COGS to revenue (%): 47.76359624044873
R&D to revenue (%): 14.829624659178437
SG&A to revenue (%): 39.822418380028445
Free cash flow (dilution-adjusted): 22536000
Buyback yield (%): 0
Retained earnings: 197049000
Receivables turnover: 10.267082613673853
Capitalized R&D asset: 156913000
ROCI (R&D-adjusted, %): 3.9668941145980434
FCF margin (%): 2.1298453367104395
Rule of 40 score: 2.1298453367104395
Financial ratios for BLKB — annual report dated 2023-12-31
Total revenue: 1107080000
Gross profit: 599055000
Operating income: 46353000
Net income: 3018000
Capital expenditures: 4685000
Operating cash flow: 199634000
Depreciation & amortization: 109487000
Net tangible assets: -987164000
Owner earnings: 107820000
Return on net tangible assets (%): -10.922197324861928
Capex to operating income (%): 10.107220676115894
Buffett classification: The Great
Stock price: 86.7
P/E ratio: 1319.5207389662028
Shares outstanding: 45932106
Book value: 808705000
P/B ratio: 4.92430934667153
Market cap (USD): 3982313590.2000003
Debt to equity: 1.0136564012835336
Current ratio: 0.7766504585523628
Quick ratio: 0.7766504585523628
Effective tax rate (%): 84.35620982790795
Interest coverage ratio: 1.1610891237913932
COGS to revenue (%): 45.8887343281425
R&D to revenue (%): 13.320356252484011
SG&A to revenue (%): 36.32041044910937
Free cash flow (dilution-adjusted): 7744000
Buyback yield (%): 0.472865824688966
Retained earnings: 198869000
Receivables turnover: 10.83089566110649
Capitalized R&D asset: 252598710
ROCI (R&D-adjusted, %): 4.693707841212474
Rosenberg metric: 0.29531651297215655
FCF margin (%): 0.6994977779383604
Revenue growth (%): 4.628557657321343
Rule of 40 score: 5.328055435259703
Financial ratios for BLKB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84.68
Shares outstanding: 45932106
Market cap (USD): 3889530736.0800004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLKB — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1206867000
Buffett classification: The Gruesome
Stock price: 73.92
Shares outstanding: 45932106
Market cap (USD): 3395301275.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLKB — annual report dated 2024-12-31
Total revenue: 1154624000
Gross profit: 631426000
Operating income: 133983000
Net income: -299524000
Capital expenditures: 7443000
Operating cash flow: 295969000
Depreciation & amortization: 121665000
Net tangible assets: -1206867000
Owner earnings: -185302000
Capex to operating income (%): 5.5551823738832535
Buffett classification: The Great
Stock price: 73.92
Shares outstanding: 45932106
Book value: 126839000
P/B ratio: 26.768590697813767
Market cap (USD): 3395301275.52
Debt to equity: 8.780107064861754
Current ratio: 0.7799920929991094
Quick ratio: 0.7799920929991094
Interest coverage ratio: 2.4082934895926953
COGS to revenue (%): 45.31327947453024
R&D to revenue (%): 13.30996064519705
SG&A to revenue (%): 29.466042625131646
Free cash flow (dilution-adjusted): 123801000
Buyback yield (%): 12.312132741032736
Retained earnings: -99457000
Receivables turnover: 13.502952905542106
Capitalized R&D asset: 304264180
ROCI (R&D-adjusted, %): 8.718223291592505
Rosenberg metric: 0.21951351827866575
FCF margin (%): 10.722191813092401
Revenue growth (%): 4.294540593272393
Rule of 40 score: 15.016732406364794
Financial ratios for BLKB — quarterly report dated 2025-03-31
Total revenue: 269936000
Gross profit: 155121000
Operating income: 19705000
Net income: 4323000
Capital expenditures: 688000
Operating cash flow: 1388000
Depreciation & amortization: 21647000
Net tangible assets: -1297566000
Owner earnings: 25282000
Return on net tangible assets (%): -1.9484172674068216
Capex to operating income (%): 3.4914996193859427
Buffett classification: The Great
Stock price: 62.05
P/E ratio: 164.82114141221373
Shares outstanding: 45932106
Book value: 33175000
P/B ratio: 85.91069110173324
Market cap (USD): 2850087177.2999997
Debt to equity: 36.41561416729465
Current ratio: 0.7263033367365129
Quick ratio: 0.7263033367365129
Effective tax rate (%): 11.140801644398767
Interest coverage ratio: 1.1628799055768664
COGS to revenue (%): 42.534156244443125
R&D to revenue (%): 12.4322061525695
SG&A to revenue (%): 37.535934443719995
Free cash flow (dilution-adjusted): -34440000
Buyback yield (%): 3.5097172043264435
Retained earnings: -79436000
Receivables turnover: 3.2669224345552905
Capitalized R&D asset: 33559000
ROCI (R&D-adjusted, %): 3.3083047666970677
FCF margin (%): -12.758579811510876
Rule of 40 score: -12.758579811510876
Financial ratios for BLKB — quarterly report dated 2025-06-30
Total revenue: 281382000
Gross profit: 167749000
Operating income: 56686000
Net income: 25980000
Capital expenditures: 623000
Operating cash flow: 66941000
Depreciation & amortization: 21699000
Net tangible assets: -1244372000
Owner earnings: 47056000
Return on net tangible assets (%): -3.7815058519478097
Capex to operating income (%): 1.0990367992096814
Buffett classification: The Great
Stock price: 64.21
P/E ratio: 97.32701469359469
Shares outstanding: 45932106
Book value: 87950000
P/B ratio: 33.53383202114838
Market cap (USD): 2949300526.2599998
Debt to equity: 13.253519044911881
Current ratio: 0.8361748826316594
Quick ratio: 0.8361748826316594
Effective tax rate (%): 34.04919655776407
Interest coverage ratio: 3.0789202107435774
COGS to revenue (%): 40.3838909382974
R&D to revenue (%): 11.939285384281865
SG&A to revenue (%): 27.330106403394673
Free cash flow (dilution-adjusted): 24249000
Buyback yield (%): 0.10765264413478437
Retained earnings: -53456000
Receivables turnover: 1.8642841525710083
Capitalized R&D asset: 56079530
ROCI (R&D-adjusted, %): 5.2011280525621855
Rosenberg metric: 0.376292499776513
FCF margin (%): 8.61782203552466
Revenue growth (%): 4.240264358959161
Rule of 40 score: 12.858086394483822
Financial ratios for BLKB — quarterly report dated 2025-09-30
Total revenue: 281143000
Gross profit: 167490000
Operating income: 54573000
Net income: 47492000
Capital expenditures: 3494000
Operating cash flow: 139211000
Depreciation & amortization: 21306000
Net tangible assets: -1215238000
Owner earnings: 65304000
Return on net tangible assets (%): -5.37376217662713
Capex to operating income (%): 6.402433437780587
Buffett classification: The Great
Stock price: 64.31
P/E ratio: 37.9702260667138
Shares outstanding: 45932106
Book value: 108189000
P/B ratio: 27.303087530710147
Market cap (USD): 2953893736.86
Debt to equity: 9.901514941445063
Current ratio: 0.6873761273620534
Quick ratio: 0.6873761273620534
Effective tax rate (%): -15.709969788519636
Interest coverage ratio: 3.253427924168356
COGS to revenue (%): 40.42533514972808
R&D to revenue (%): 13.230989211895725
SG&A to revenue (%): 26.72981365354997
Free cash flow (dilution-adjusted): 101579000
Buyback yield (%): 1.0201111713663569
Retained earnings: -21176000
Receivables turnover: 3.248067747264808
Capitalized R&D asset: 70781120
ROCI (R&D-adjusted, %): 4.5741824400389355
Rosenberg metric: -0.0077094805774668845
FCF margin (%): 36.13072351081122
Revenue growth (%): -0.08493791358366917
Rule of 40 score: 36.04578559722756
Financial ratios for BLKB — quarterly report dated 2025-12-31
Total revenue: 295256000
Gross profit: 172284000
Operating income: 59142000
Net income: 36689000
Capital expenditures: 2962000
Operating cash flow: 58010000
Depreciation & amortization: 21563000
Net tangible assets: -1234257000
Owner earnings: 55290000
Return on net tangible assets (%): -4.479618102226683
Capex to operating income (%): 5.008285144229144
Buffett classification: The Great
Stock price: 63.32
P/E ratio: 25.404606337304774
Shares outstanding: 45932106
Book value: 85054000
P/B ratio: 34.19499320337668
Market cap (USD): 2908420951.92
Debt to equity: 13.119441766407224
Current ratio: 0.7868149345018801
Quick ratio: 0.7868149345018801
Effective tax rate (%): 19.95069055047673
Interest coverage ratio: 3.7337121212121214
COGS to revenue (%): 41.64928062427182
R&D to revenue (%): 11.440241688568564
SG&A to revenue (%): 26.68870403988403
Free cash flow (dilution-adjusted): 19249000
Buyback yield (%): 2.8817699152067386
Retained earnings: 15513000
Receivables turnover: 3.608383745798961
Capitalized R&D asset: 69787010
ROCI (R&D-adjusted, %): 4.5419415246090615
Rosenberg metric: 0.12887789666111082
FCF margin (%): 6.519427208930555
Revenue growth (%): 5.019865335434281
Rule of 40 score: 11.539292544364836
Financial ratios for BLKB — annual report dated 2025-12-31
Total revenue: 1128365000
Gross profit: 663292000
Operating income: 190754000
Net income: 114970000
Capital expenditures: 7767000
Operating cash flow: 265550000
Depreciation & amortization: 86215000
Net tangible assets: -1234257000
Owner earnings: 193418000
Return on net tangible assets (%): -15.67080437866668
Capex to operating income (%): 4.071736372500707
Buffett classification: The Great
Stock price: 63.32
P/E ratio: 25.297216247020962
Shares outstanding: 45932106
Book value: 85054000
P/B ratio: 34.19499320337668
Market cap (USD): 2908420951.92
Debt to equity: 13.119441766407224
Current ratio: 0.7868149345018801
Quick ratio: 0.7868149345018801
Effective tax rate (%): 12.75809474666687
Interest coverage ratio: 2.8064440194203324
COGS to revenue (%): 41.216538974533954
R&D to revenue (%): 12.241606217846176
SG&A to revenue (%): 29.43852388189992
Free cash flow (dilution-adjusted): 110637000
Buyback yield (%): 7.4663194767816075
Retained earnings: 15513000
Receivables turnover: 13.78997861289337
Capitalized R&D asset: 289759710
ROCI (R&D-adjusted, %): 12.177310639493669
Rosenberg metric: 0.2073529411764706
FCF margin (%): 9.805071940373903
Revenue growth (%): -2.2742468543872287
Rule of 40 score: 7.530825085986674
Financial ratios for CAKE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.92
Shares outstanding: 49685363
Market cap (USD): 1735012875.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAKE — annual report dated 2022-12-31
Total revenue: 3303156000
Gross profit: 1280279000
Operating income: 100519000
Net income: 43123000
Capital expenditures: 112464000
Operating cash flow: 161926000
Depreciation & amortization: 92380000
Net tangible assets: 40479000
Owner earnings: 23039000
Return on net tangible assets (%): 56.91593171768077
Capex to operating income (%): 111.88332554044509
Buffett classification: The Gruesome
Stock price: 28.98
P/E ratio: 33.390112462954804
Shares outstanding: 49685363
Book value: 292003000
P/B ratio: 4.931051460909648
Market cap (USD): 1439881819.74
Debt to equity: 6.303455786413153
Current ratio: 0.5265411662945919
Quick ratio: 0.441935012289128
Effective tax rate (%): -31.104827921683082
Interest coverage ratio: 13.424011752136753
COGS to revenue (%): 61.24073461864956
SG&A to revenue (%): 6.228982221850861
Free cash flow (dilution-adjusted): 24356000
Buyback yield (%): 4.38452650311258
Retained earnings: 1170078000
Inventory turnover: 36.40952860922623
Receivables turnover: 26.00234584714208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.744725381889998
FCF margin (%): 0.7373554261439665
Rule of 40 score: 0.7373554261439665
Financial ratios for CAKE — annual report dated 2023-12-31
Total revenue: 3439503000
Gross profit: 1408108000
Operating income: 175095000
Net income: 101351000
Capital expenditures: 151565000
Operating cash flow: 218401000
Depreciation & amortization: 93136000
Net tangible assets: 66335000
Owner earnings: 42922000
Return on net tangible assets (%): 64.70490691188664
Capex to operating income (%): 86.56158085610669
Buffett classification: The Gruesome
Stock price: 33.04
P/E ratio: 16.197219499758265
Shares outstanding: 49685363
Book value: 318062000
P/B ratio: 5.161271681370299
Market cap (USD): 1641604393.52
Debt to equity: 5.847624048141557
Current ratio: 0.45529166559452433
Quick ratio: 0.3680258403955978
Effective tax rate (%): -1.3368128462015318
Interest coverage ratio: 17.233759842519685
COGS to revenue (%): 59.06071313210077
SG&A to revenue (%): 6.3221052576491426
Free cash flow (dilution-adjusted): 39397000
Buyback yield (%): 2.807314611359106
Retained earnings: 1216239000
Inventory turnover: 35.234242203489785
Receivables turnover: 27.790819624446527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.032941966645135
FCF margin (%): 1.1454271154873248
Revenue growth (%): 4.127779614405132
Rule of 40 score: 5.273206729892458
Financial ratios for CAKE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.12
Shares outstanding: 49685363
Market cap (USD): 1943691400.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAKE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.03
Shares outstanding: 49685363
Market cap (USD): 2287017258.89
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAKE — annual report dated 2024-12-31
Total revenue: 3581699000
Gross profit: 1511296000
Operating income: 221888000
Net income: 156783000
Capital expenditures: 160364000
Operating cash flow: 268325000
Depreciation & amortization: 101450000
Net tangible assets: 191666000
Owner earnings: 97869000
Return on net tangible assets (%): 51.06226456439848
Capex to operating income (%): 72.27249783674647
Buffett classification: The Good
Stock price: 46.03
P/E ratio: 14.587150768195531
Shares outstanding: 49685363
Book value: 443455000
P/B ratio: 5.157270205297042
Market cap (USD): 2287017258.89
Debt to equity: 4.303074720095613
Current ratio: 0.468517893789885
Quick ratio: 0.3778176042281634
Effective tax rate (%): 8.339228399211912
Interest coverage ratio: 21.95389334124864
COGS to revenue (%): 57.8050528534084
SG&A to revenue (%): 6.3862708731247375
Free cash flow (dilution-adjusted): 76945000
Buyback yield (%): 0.7970206577648185
Retained earnings: 1317828000
Inventory turnover: 32.08633729039457
Receivables turnover: 27.568495997536946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.521700696035772
FCF margin (%): 2.1482821420783824
Revenue growth (%): 4.134201947199929
Rule of 40 score: 6.282484089278311
Financial ratios for CAKE — quarterly report dated 2025-03-31
Total revenue: 927197000
Gross profit: 393861000
Operating income: 61422000
Net income: 32941000
Capital expenditures: 42816000
Operating cash flow: 78919000
Depreciation & amortization: 26082000
Net tangible assets: 87232000
Owner earnings: 16207000
Return on net tangible assets (%): 18.579191122523845
Capex to operating income (%): 69.70792224284459
Buffett classification: The Good
Stock price: 47.47
P/E ratio: 17.899913342111656
Shares outstanding: 49685363
Book value: 339405000
P/B ratio: 6.949114425568274
Market cap (USD): 2358564181.61
Debt to equity: 6.193167454810625
Current ratio: 0.5278992547624582
Quick ratio: 0.43007823751394486
Effective tax rate (%): 4.471768697619117
Interest coverage ratio: 26.3840206185567
COGS to revenue (%): 57.52132502585751
SG&A to revenue (%): 6.463782777554285
Free cash flow (dilution-adjusted): 27985000
Buyback yield (%): 5.993434526912289
Retained earnings: 1337688000
Inventory turnover: 7.971660887241421
Receivables turnover: 8.949173318405126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5308611199128443
FCF margin (%): 3.01823668540774
Rule of 40 score: 3.01823668540774
Financial ratios for CAKE — quarterly report dated 2025-06-30
Total revenue: 955825000
Gross profit: 416463000
Operating income: 75103000
Net income: 54812000
Capital expenditures: 41549000
Operating cash flow: 56844000
Depreciation & amortization: 26860000
Net tangible assets: 148816000
Owner earnings: 40123000
Return on net tangible assets (%): 26.96148263627567
Capex to operating income (%): 55.32269017216356
Buffett classification: The Good
Stock price: 61.43
P/E ratio: 34.781396067256956
Shares outstanding: 49685363
Book value: 400948000
P/B ratio: 7.612388262542774
Market cap (USD): 3052171849.09
Debt to equity: 5.238010914133503
Current ratio: 0.514737746132232
Quick ratio: 0.42463160722498927
Effective tax rate (%): 11.918880264828296
Interest coverage ratio: 26.140967629655414
COGS to revenue (%): 56.42894881385191
SG&A to revenue (%): 6.149452044045719
Free cash flow (dilution-adjusted): 8106000
Buyback yield (%): 0.004292025694393893
Retained earnings: 1379162000
Inventory turnover: 8.121331666992909
Receivables turnover: 9.014835703776361
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.110046955277986
FCF margin (%): 0.8480631914837966
Revenue growth (%): 3.0875854861480354
Rule of 40 score: 3.935648677631832
Financial ratios for CAKE — quarterly report dated 2025-09-30
Total revenue: 907226000
Gross profit: 386798000
Operating income: 44659000
Net income: 31899000
Capital expenditures: 36683000
Operating cash flow: 90611000
Depreciation & amortization: 27419000
Net tangible assets: 173241000
Owner earnings: 22635000
Return on net tangible assets (%): 13.065613798119383
Capex to operating income (%): 82.14021809713607
Buffett classification: The Gruesome
Stock price: 53.81
P/E ratio: 22.344544036288568
Shares outstanding: 49685363
Book value: 425349000
P/B ratio: 6.2855899109437186
Market cap (USD): 2673569383.03
Debt to equity: 5.029046735739358
Current ratio: 0.5495726617604546
Quick ratio: 0.46736789978778925
Effective tax rate (%): 10.095544094022154
Interest coverage ratio: 19.87494437027147
COGS to revenue (%): 57.36475806469391
SG&A to revenue (%): 6.502900049160848
Free cash flow (dilution-adjusted): 47887000
Buyback yield (%): 0.04608071919958008
Retained earnings: 1397655000
Inventory turnover: 8.206960717833883
Receivables turnover: 8.154180785374667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8080925492044173
FCF margin (%): 5.27839810587439
Revenue growth (%): -5.084508147411921
Rule of 40 score: 0.19388995846246893
Financial ratios for CAKE — quarterly report dated 2025-12-31
Total revenue: 961558000
Gross profit: 428643000
Operating income: 76620000
Net income: 28775000
Capital expenditures: 25156000
Operating cash flow: 74907000
Depreciation & amortization: 28670000
Net tangible assets: 184621000
Owner earnings: 32289000
Return on net tangible assets (%): 17.48934303248276
Capex to operating income (%): 32.83215870529887
Buffett classification: The Good
Stock price: 49.99
P/E ratio: 16.73395875662784
Shares outstanding: 49685363
Book value: 436427000
P/B ratio: 5.6911494851830895
Market cap (USD): 2483771296.37
Debt to equity: 4.880163234630305
Current ratio: 0.5853559344719702
Quick ratio: 0.5158987453202079
Effective tax rate (%): 6.2764640740016935
Interest coverage ratio: 25.54
COGS to revenue (%): 55.42203382427269
SG&A to revenue (%): 6.9895939714505
Free cash flow (dilution-adjusted): 42809000
Buyback yield (%): 0.44988039020865805
Retained earnings: 1412942000
Inventory turnover: 9.874464970631289
Receivables turnover: 7.372780248428155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0837204753485485
FCF margin (%): 4.452045534434741
Revenue growth (%): 5.988805435470324
Rule of 40 score: 10.440850969905064
Financial ratios for CAKE — annual report dated 2025-12-31
Total revenue: 3751806000
Gross profit: 1625765000
Operating income: 257804000
Net income: 148427000
Capital expenditures: 146204000
Operating cash flow: 301281000
Depreciation & amortization: 109031000
Net tangible assets: 184621000
Owner earnings: 111254000
Return on net tangible assets (%): 60.26075040217527
Capex to operating income (%): 56.71130005740795
Buffett classification: The Good
Stock price: 49.99
P/E ratio: 16.73395875662784
Shares outstanding: 49685363
Book value: 436427000
P/B ratio: 5.6911494851830895
Market cap (USD): 2483771296.37
Debt to equity: 4.880163234630305
Current ratio: 0.5853559344719702
Quick ratio: 0.5158987453202079
Effective tax rate (%): 8.88179502133276
Interest coverage ratio: 24.674961715160798
COGS to revenue (%): 56.66713577407787
SG&A to revenue (%): 6.527922819037019
Free cash flow (dilution-adjusted): 126787000
Buyback yield (%): 6.196061619075679
Retained earnings: 1412942000
Inventory turnover: 39.393744557060536
Receivables turnover: 28.767106272044163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.375821892805497
FCF margin (%): 3.379359167291699
Revenue growth (%): 4.749338233056434
Rule of 40 score: 8.128697400348134
Financial ratios for CAML3.SA — annual report dated 2022-02-28
Operating income: 123435852.71317829
Capital expenditures: 45704457.36434109
Capex to operating income (%): 37.026889967327605
Buffett classification: The Good
Stock price: 1.47265625
Shares outstanding: 341071232
Market cap (USD): 502280681.5
Buyback yield (%): 0
Retained earnings: 285046317.82945734
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAML3.SA — annual report dated 2023-02-28
Total revenue: 1962593846.153846
Gross profit: 407665961.5384615
Operating income: 93873461.53846154
Net income: 68016153.84615384
Capital expenditures: 207115.3846153846
Operating cash flow: -26714038.46153846
Depreciation & amortization: 45006153.84615385
Net tangible assets: 356601538.46153843
Owner earnings: 112815192.30769229
Return on net tangible assets (%): 31.636204598107774
Capex to operating income (%): 0.2206325208648303
Buffett classification: The Great
Stock price: 1.3346153846153845
P/E ratio: 6.692511818685607
Shares outstanding: 341071232
Book value: 576811923.0769231
P/B ratio: 0.7891634955268046
Market cap (USD): 455198913.47692305
Debt to equity: 1.3924822849202279
Current ratio: 1.98806860260396
Quick ratio: 1.1228449328687917
Effective tax rate (%): 10.510721740780566
Interest coverage ratio: 1.2218120108229065
COGS to revenue (%): 79.22820545181182
SG&A to revenue (%): 16.137493866045403
Free cash flow (dilution-adjusted): -28438076.92307692
Buyback yield (%): 4.287770475175816
Retained earnings: 51192307.69230769
Inventory turnover: 3.6521592823621343
Receivables turnover: 7.663768516446464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.33487140511783
FCF margin (%): -1.449004692377278
Rule of 40 score: -1.449004692377278
Financial ratios for CAML3.SA — annual report dated 2024-02-29
Total revenue: 2263510462.77666
Gross profit: 457942052.3138833
Operating income: 126491951.71026157
Net income: 72527364.18511067
Capital expenditures: 123340.0402414487
Operating cash flow: 105422535.2112676
Depreciation & amortization: 52705633.802816905
Net tangible assets: 398895975.8551308
Owner earnings: 125109657.94768614
Return on net tangible assets (%): 31.363980967590127
Capex to operating income (%): 0.09750821184573662
Buffett classification: The Great
Stock price: 1.5412474849094568
P/E ratio: 7.24795646996485
Shares outstanding: 341071232
Book value: 621196378.2696178
P/B ratio: 0.8462302693381305
Market cap (USD): 525675178.49496984
Debt to equity: 1.8638319125877045
Current ratio: 2.1561736193467493
Quick ratio: 1.5043806145456435
Effective tax rate (%): -57.8421670286555
Interest coverage ratio: 1.0863250551227908
COGS to revenue (%): 79.76850295835949
SG&A to revenue (%): 14.953278089525831
Free cash flow (dilution-adjusted): 104393158.95372233
Buyback yield (%): 2.4918801014211294
Inventory turnover: 4.674356315115324
Receivables turnover: 8.275651093486895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.190013151389493
FCF margin (%): 4.612002492167087
Revenue growth (%): 15.332597583169298
Rule of 40 score: 19.944600075336385
Financial ratios for CAML3.SA — quarterly report dated 2024-11-30
Total revenue: 516574875.2079867
Gross profit: 88891014.9750416
Operating income: 17151913.47753744
Net income: 7381364.392678869
Capital expenditures: 21529450.915141433
Operating cash flow: -35907487.52079867
Depreciation & amortization: 11358901.830282863
Net tangible assets: 397240266.2229617
Owner earnings: -2789184.692179702
Return on net tangible assets (%): -0.7021404750076866
Capex to operating income (%): 125.52215205222976
Buffett classification: The Gruesome
Stock price: 1.0948419301164727
P/E ratio: 12.647359826878862
Shares outstanding: 341071232
Book value: 591226622.2961731
P/B ratio: 0.6316005942016261
Market cap (USD): 373419085.95008326
Debt to equity: 1.7442945544275812
Current ratio: 2.037984709296164
Quick ratio: 1.2108172133565933
Interest coverage ratio: 0.6527380258858692
COGS to revenue (%): 82.79223027653993
SG&A to revenue (%): 14.406778296181653
Free cash flow (dilution-adjusted): -14735940.099833611
Buyback yield (%): 0
Retained earnings: 36691347.75374376
Inventory turnover: 0.8901286513254723
Receivables turnover: 1.570006973617072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2266658543078006
FCF margin (%): -2.8526242384321403
Rule of 40 score: -2.8526242384321403